Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment/Experiment 5
From BugSigDB
Reviewed Marked as Reviewed by Claregrieve1 on 2022/06/22
Curated date: 2021/06/27
Curator: Madhubani Dey
Revision editor(s): Madhubani Dey, WikiWorks, Victoria
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Periodontitis chronic pericementitis,inflammation of periodontium,Pericementitides,Pericementitis,Periodontitides,periodontitis,Periodontitis (disorder),Periodontitis, NOS,periodontium inflammation,periodontosis,Periodontitis
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Individuals diagnosed with Periodontitis and Type 2 Diabetes Mellitus (DAP)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Individuals diagnosed with both Periodontitis and Type 2 Diabetes and treated with metformin (Met group)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with both Periodontitis and Type 2 Diabetes who received metformin for at least 6 months and achieved glycemic control (HbA1c < 6.5%, without any companion diseases), were classified into the Met group
- Group 0 sample size Number of subjects in the control (unexposed) group
- 46
- Group 1 sample size Number of subjects in the case (exposed) group
- 20
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- patients treated with antibiotics within 3 months or those that received periodontal treatment within 6 months
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Mann-Whitney (Wilcoxon)
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
Signature 1
Reviewed Marked as Reviewed by Claregrieve1 on 2022/06/22
Source: Figure 5c, 5d
Description: Decreased abundance of bacterial communities in Met group compared to DAP group
Abundance in Group 1: decreased abundance in Individuals diagnosed with both Periodontitis and Type 2 Diabetes and treated with metformin (Met group)
| NCBI | Quality Control | Links |
|---|---|---|
| Alloprevotella rava | ||
| Phyllobacterium myrsinacearum | ||
| Segatella copri | ||
| Ralstonia pickettii | ||
| Sutterella stercoricanis |
Revision editor(s): Madhubani Dey
Signature 2
Reviewed Marked as Reviewed by Claregrieve1 on 2022/06/22
Source: Figure 5c, 5d
Description: Increased abundance of bacterial communities in individuals of Met group compared to DAP group
Abundance in Group 1: increased abundance in Individuals diagnosed with both Periodontitis and Type 2 Diabetes and treated with metformin (Met group)
| NCBI | Quality Control | Links |
|---|---|---|
| Prevotella jejuni | ||
| Streptobacillus moniliformis | ||
| Streptococcus mutans |
Revision editor(s): Madhubani Dey
